Italy probes Biogen over Tysabri test and market abuse claims
Italy’s AGCM is investigating Biogen over alleged market abuse tied to anti-JCV testing for Tysabri, with potential effects on Sandoz.
Biogen
Lars Rose nominated as next MVFP chair
MVFP has nominated Lars Joachim Rose as candidate for chair of its board. He is set to succeed Philipp Welte, who will not seek re-election in 2026.
Pierre Fabre strengthens its pharmacy sales team
Pierre Fabre appoints Özgül Gebel as Commercial Sales Director. She will expand wholesaler and e-commerce ties, while keeping pharmacies central.
Mathias Arnold elected European pharmacists’ president for 2027
PGEU’s General Assembly has elected German pharmacist Mathias Arnold as president for 2027. He will succeed Poland’s Dr Mikolaj Konstanty.
Skin cancer prevention: BVDD continues May 2026 campaign
BVDD will continue its skin cancer prevention month in May 2026. The focus is on UV protection, early detection and practice-ready tools.
Biogen completes acquisition of Apellis Pharmaceuticals
Biogen has completed its acquisition of Apellis. The deal adds SYFOVRE and EMPAVELI and is positioned to support Biogen’s nephrology expansion.
Health system under pressure: sustainability as a lever for prevention
At WeACT Con, experts discussed how prevention and environmental health can reduce risks and help stabilize healthcare, from funding ideas to guidance.
Orifarm appoints Pierre Bourdage to Board of Directors
Orifarm has appointed Pierre Bourdage to its Board of Directors, effective May 1. The former Sandoz CCO brings international pharma expertise.
Tyra Biosciences and BCAN establish UTUC Awareness Day
Tyra Biosciences and BCAN set May 21 as UTUC Awareness Day, highlighting the rare cancer’s burden and the need for continued research.
Ryan Reynolds launches Parkinson’s non-motor symptom campaign
Ryan Reynolds and Acadia launched “More to Parkinson’s” to raise awareness of hallucinations and delusions in Parkinson’s and improve patient-doctor dialogue.